<DOC>
	<DOCNO>NCT00109499</DOCNO>
	<brief_summary>The primary purpose study assess safety AdGVPEDF.11D give patient `` wet '' age-related macular degeneration ( AMD ) . AdGVPEDF.11D replication deficient ( E1 , E3 E4 delete ) adenovirus vector contain gene PEDF ( pigment epithelium-derived factor ) protein . PEDF protein naturally exist human eye , whose level alter disease characterize ocular neovascularization like AMD . The PEDF protein know anti-angiogenic effect , word , ability inhibit growth new blood vessel . AdGVPEDF.11D deliver via intravitreal injection one eye . The injected eye eye bad visual acuity .</brief_summary>
	<brief_title>Study AdGVPEDF.11D Neovascular Age-related Macular Degeneration ( AMD )</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<criteria>Age great equal 50 year ; Severe neovascular AMD least one eye responsible best correct vision 20/200 worse study eye ( eyes neovascular AMD equal visual acuity score , study eye determine investigator ) ; Best correct visual acuity fellow eye must equal good study eye ; Fluorescein angiography study eye must show evidence leak subfoveal choroidal neovascular lesion . The subfoveal component must consist CNV ( choroidal neovascularization ) , blood fibrosis . The total size lesion must â‰¤12 MPS disc area . The presence leak subfoveal choroidal neovascular lesion evaluate investigator clinical site determine patient ' eligibility . Must candidate ( include patient treatment either modality past longer candidate ) must refuse treatment subfoveal laser photocoagulation PDT ( photodynamic therapy ) ; Informed consent ; Able comply protocol requirement include followup visit . Liver enzymes &gt; 2 x ULN ( ALT , AST , bilirubin ) ; Clinical evidence active infection type , include adenovirus , hepatitis A , B , C virus HIV virus ; Other treatment AMD study eye within last twelve week prior Day 1 ; Other experimental medication within last four week prior Day 1 ; Significant retinal disease neovascular AMD , diabetic retinopathy retinal vascular occlusion ; Significant nonretinal disease ocular atrophy ; Cataract significant medium opacity might compromise examination photography posterior segment ; Other cause choroidal neovascularization pathologic myopia ( &gt; 8 diopter ) , ocular histoplasmosis angioid streak ; Evidence inflammation ( grade 1 high ) anterior and/or posterior chamber ; Cataract surgery submacular surgery within 3 month ; Prior ocular treatment radiation ; Known allergy fluorescein ; Abnormal prothrombin partial thromboplastin time ( &gt; 1.5 X ULN ) anticoagulant therapy withheld treatment .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Wet Age-Related Macular Degeneration</keyword>
	<keyword>Age-Related Maculopathies</keyword>
</DOC>